Bortezomib NewsLatest News On Bortezomib Myeloma Expert: Is Early Immunotherapy a Game Changer?7/31/2025 9:09 AM FDA Advisory Panel Votes NO on Belantamab for Myeloma7/21/2025 12:50 AM Linvoseltamab Approved for R/R Multiple Myeloma7/2/2025 5:48 PM Darzalex Monotherapy OK'd for Smoldering Multiple Myeloma6/20/2025 1:37 PM Blenrep Gets European Nod to Treat Multiple Myeloma5/23/2025 10:44 AM Daratumumab Confirmed as SOC for AL Amyloidosis12/17/2024 6:55 AM FDA Expands Darzalex Faspro Indication in Myeloma8/1/2024 1:43 AM Myeloma: First-in-Class ADC Regimen Yields Key Benefits6/7/2024 4:33 AM New Agent Shows Early Promise in Triple-Class Refractory Multiple Myeloma4/17/2024 6:26 AM
